From Our Partners
Saturday, July 2, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home News Scan

Biodefense Headlines – October 14, 2012

by Global Biodefense Staff
October 14, 2012

Defenders of fusion centers hit back at senate panel’s criticisms | Changes in select agent rules concern public health labs | Taking up the fight against ‘superbugs’ | Bioethics Commission Report on Genomics and Privacy | Development of 2 tests for rapid diagnosis of resistance to antibiotics | Grand Challenges: TB vaccine accelerator grant opportunity | Aeras signs agreement with GSK to jointly advance TB vaccine | Biologists describe new mechanism for molecular interactions | Feds: old potato behind Utah home brew botulism | Genetic sleuthing uncovers deadly new virus in Africa | Germ killing protein in eyes could lead to new antimicrobial drugs | Protecting civilian emergency responders against anthrax | DTRA program working on unique chem-bio defense projects | Jordan plays down presence of U.S. chemical-response troops | Majority of US Schools not ready for next pandemic | Experts ponder H5N1 research moratorium issues

See what we’re reading this week at Global Biodefense on topics like select agent rule changes, TB vaccine grants, home-brew botulism, emergency responder anthrax protection and more…

Defenders of fusion centers hit back at senate panel’s criticisms (NTI GSN)

Changes in select agent rules concern public health labs (CIDRAP)

Taking up the fight against ‘superbugs’ (UCLA Today)

Bioethics Commission Report on Genomics and Privacy (Bioethics.gov)

Development of 2 tests for rapid diagnosis of resistance to antibiotics (EurekAlert)

Grand Challenges: TB vaccine accelerator grant opportunity (Gates Foundation)

Aeras signs agreement with GSK to jointly advance TB vaccine (PRNewswire)

Biologists describe new mechanism for molecular interactions (Brookhaven)

Feds: old potato behind Utah home brew botulism (Seattle Times)

Genetic sleuthing uncovers deadly new virus in Africa (EurekAlert)

Germ killing protein in eyes could lead to new antimicrobial drugs (UC Berkeley)

Protecting civilian emergency responders against anthrax (DomPrep)

DTRA program working on unique chem-bio defense projects (BioPrepWatch)

Jordan plays down presence of U.S. chemical-response troops (NTI GSN)

Majority of US Schools not ready for next pandemic, SLU researchers say (SLU)

Experts ponder H5N1 research moratorium issues (CIDRAP)

From Our Partners

Related Posts

Biodefense Headlines – 16 June 2022
News Scan

Biodefense Headlines – 16 June 2022

June 16, 2022
Biodefense Headlines – 29 May 2022
News Scan

Biodefense Headlines – 29 May 2022

May 29, 2022
Biodefense Headlines – 4 May 2022
News Scan

Biodefense Headlines – 4 May 2022

May 4, 2022
Biodefense Headlines – 5 April 2022
News Scan

Biodefense Headlines – 5 April 2022

April 5, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC